LUIS
BUJANDA FERNÁNDEZ DE PIÉROLA
Universidade de Vigo
Vigo, EspañaUniversidade de Vigo-ko ikertzaileekin lankidetzan egindako argitalpenak (14)
2023
-
Serum methylation of GALNT9, UPF3A, WARS, and LDB2 as noninvasive biomarkers for the early detection of colorectal cancer and advanced adenomas
Clinical Epigenetics, Vol. 15, Núm. 1
2022
-
Evaluation of Blood Soluble CD26 as a Complementary Biomarker for Colorectal Cancer Screening Programs
Cancers, Vol. 14, Núm. 19
-
Quality of Colonoscopy Is Associated With Adenoma Detection and Postcolonoscopy Colorectal Cancer Prevention in Lynch Syndrome
Clinical Gastroenterology and Hepatology, Vol. 20, Núm. 3, pp. 611-621.e9
-
Real-world use of mycophenolate mofetil in inflammatory bowel disease: Results from the ENEIDA registry
Digestive and Liver Disease, Vol. 54, Núm. 5, pp. 635-641
2021
-
Optimal diagnostic accuracy of quantitative faecal immunochemical test positivity thresholds for colorectal cancer detection in primary health care: A community-based cohort study
United European Gastroenterology Journal, Vol. 9, Núm. 2, pp. 256-267
2020
-
Predictive value of carcinoembryonic antigen in symptomatic patients without colorectal cancer: A post-hoc analysis within the colonpredict cohort
Diagnostics, Vol. 10, Núm. 12
-
Retrospective cohort study: Risk of gastrointestinal cancer in a symptomatic cohort after a complete colonoscopy: Role of faecal immunochemical test
World Journal of Gastroenterology, Vol. 26, Núm. 1, pp. 70-85
2019
-
Effectiveness and safety of the switch from remicade® to CT-P13 in patients with inflammatory bowel disease
Journal of Crohn's and Colitis, Vol. 13, Núm. 11, pp. 1380-1386
-
High incidence of advanced colorectal neoplasia during endoscopic surveillance in serrated polyposis syndrome
Endoscopy, Vol. 51, Núm. 2, pp. 142-151
2018
2016
-
Development and external validation of a faecal immunochemical test-based prediction model for colorectal cancer detection in symptomatic patients
BMC Medicine, Vol. 14, Núm. 1
-
Incidence of advanced neoplasia during surveillance in high- and intermediate-risk groups of the European colorectal cancer screening guidelines
Endoscopy, Vol. 48, Núm. 11, pp. 995-1002
2014
-
Diagnostic accuracy of fecal immunochemical test in average- and familial-risk colorectal cancer screening
United European Gastroenterology Journal, Vol. 2, Núm. 6, pp. 522-529
2010
-
Usefulness of oral beclometasone dipropionate in the treatment of active ulcerative colitis in clinical practice: The RECLICU Study
Journal of Crohn's and Colitis, Vol. 4, Núm. 6, pp. 629-636